{"id":"https://openalex.org/W2462641083","doi":null,"title":"A phase II study of doxorubicin/paclitaxel plus G-CSF for metastatic breast cancer.","display_name":"A phase II study of doxorubicin/paclitaxel plus G-CSF for metastatic breast cancer.","publication_year":1997,"publication_date":"1997-04-01","ids":{"openalex":"https://openalex.org/W2462641083","mag":"2462641083","pmid":"https://pubmed.ncbi.nlm.nih.gov/9144687"},"language":"en","primary_location":{"id":"pmid:9144687","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9144687","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology (Williston Park, N.Y.)","raw_type":"Clinical Trial"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044040883","display_name":"Gilberto Schwartsmann","orcid":"https://orcid.org/0000-0002-7850-1644","observed_orcids":["https://orcid.org/0000-0002-7850-1644"]},"institutions":[{"id":"https://openalex.org/I4210097146","display_name":"Hospital de Cl\u00ednicas de Porto Alegre","ror":"https://ror.org/010we4y38","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210097146"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"G Schwartsmann","raw_affiliation_strings":["Medical Oncology Unit, Hospital de Clinicas de Porto Alegre, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit, Hospital de Clinicas de Porto Alegre, Brazil","institution_ids":["https://openalex.org/I4210097146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010612729","display_name":"Dennis R.A. Mans","orcid":"https://orcid.org/0000-0001-5080-5227","observed_orcids":["https://orcid.org/0000-0001-5080-5227"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D R Mans","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087319335","display_name":"Menke Ch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C H Menke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113685281","display_name":"Nilton Leite Xavier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Xavier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087285316","display_name":"Maira M Caleffi","orcid":"https://orcid.org/0000-0002-9494-9457","observed_orcids":["https://orcid.org/0000-0002-9494-9457"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Caleffi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039794921","display_name":"Ferreira Filho Af","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A F Ferreira Filho","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071868716","display_name":"Holger Jens Sch\u00fcnemann","orcid":"https://orcid.org/0000-0003-3211-8479","observed_orcids":["https://orcid.org/0000-0003-3211-8479"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Schunemann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064953594","display_name":"Luciane Kalakun","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Kalakun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"R Koya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Koya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054136402","display_name":"Paula Pohlman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Pohlman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5071785897","display_name":"Venegas Tresierra Lf","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L F Venegas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6068,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.71524805,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"11","issue":"4 Suppl 3","first_page":"24","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.026399999856948853,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9679999947547913},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.9940000176429749},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.847000002861023},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6800000071525574},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.8009999990463257},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.8330000042915344},{"id":"https://openalex.org/keywords/leukopenia","display_name":"leukopenia","score":0.7900000214576721},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.902999997138977},{"id":"https://openalex.org/keywords/mucositis","display_name":"mucositis","score":0.9879999756813049},{"id":"https://openalex.org/keywords/alopecia","display_name":"hair loss","score":0.7409999966621399},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7919999957084656},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.652999997138977}],"concepts":[{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.8944367170333862},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.860325813293457},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.7550462484359741},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6639996767044067},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.6549046039581299},{"id":"https://openalex.org/C2780873365","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukopenia","level":3,"score":0.6114007830619812},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.5601088404655457},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.558208703994751},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5253918766975403},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5063258409500122},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.47772523760795593},{"id":"https://openalex.org/C2777767877","wikidata":"https://www.wikidata.org/wiki/Q419327","display_name":"Granulocyte colony-stimulating factor","level":3,"score":0.476714551448822},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.47029659152030945},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.41688892245292664},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4153401851654053},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.40397757291793823},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38615769147872925},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3305552005767822},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3245842456817627}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D013534","descriptor_name":"Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9144687","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9144687","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology (Williston Park, N.Y.)","raw_type":"Clinical Trial"},{"id":"mag:2462641083","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9144687","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W25774907","https://openalex.org/W1836451026","https://openalex.org/W1888433797","https://openalex.org/W1960713055","https://openalex.org/W1986419542","https://openalex.org/W2056435407","https://openalex.org/W2109815554","https://openalex.org/W2155946383","https://openalex.org/W2248741218","https://openalex.org/W2334195749","https://openalex.org/W2345356837"],"related_works":["https://openalex.org/W2886431125","https://openalex.org/W2410195191","https://openalex.org/W2189326648","https://openalex.org/W2418036867","https://openalex.org/W2422454534","https://openalex.org/W2227235589","https://openalex.org/W2552563742","https://openalex.org/W2415904271","https://openalex.org/W1924401190","https://openalex.org/W2418142593"],"abstract_inverted_index":{"This":[0,251],"phase":[1],"II":[2],"trial":[3],"was":[4,65,90,109,172,195,202,218,230,273,299],"conducted":[5],"to":[6,41,55,103,223,235,246,280,285],"evaluate":[7],"the":[8,14,60,198,227,295],"percentage":[9],"of":[10,17,53,117,137,210,297,307],"objective":[11,207,256],"responses":[12],"and":[13,21,49,126,149,160,197,241],"toxicity":[15,171,290],"profile":[16],"combination":[18,252,309],"doxorubicin":[19,123],"(Adriamycin)":[20],"paclitaxel":[22,74,127],"(Taxol)":[23],"with":[24,33,45,261,312],"granulocyte":[25,101],"colony-stimulating":[26,86],"factor":[27,87],"as":[28,67,77,93],"first-line":[29],"therapy":[30],"for":[31,114,147,204,215,238,249,283],"patients":[32,279,311],"metastatic":[34],"breast":[35],"cancer":[36],"(MBC)":[37],"not":[38],"previously":[39],"exposed":[40],"anthracycline-containing":[42],"regimens.":[43],"Patients":[44],"measurable,":[46],"visceral-dominant":[47],"MBC":[48,313],"a":[50,68,78,94,115,254],"performance":[51],"status":[52],"0":[54],"2":[56,99,183,234],"were":[57,133,145,157,266],"included":[58],"in":[59,135,164,186,259,268,310,317],"study.":[61],"Doxorubicin":[62],"60":[63],"mg/m2":[64,76,125],"administered":[66],"short":[69],"intravenous":[70,80],"infusion,":[71],"followed":[72],"by":[73],"250":[75],"3-hour":[79],"infusion":[81],"on":[82],"day":[83,98],"1.":[84],"Granulocyte":[85],"5":[88,242],"micrograms/kg/d":[89],"given":[91],"prophylactically":[92],"subcutaneous":[95],"injection":[96],"from":[97],"until":[100],"recovery":[102],">":[104],"or":[105,184,291],"=":[106],"1,500/mm3.":[107],"Treatment":[108],"repeated":[110],"every":[111],"21":[112],"days":[113],"maximum":[116],"six":[118,286],"courses.":[119],"Dose":[120],"reductions":[121,180,265],"(to":[122],"50":[124],"175":[128],"mg/m2)":[129],"and/or":[130,176],"treatment":[131],"delay":[132],"applied":[134],"case":[136],"severe":[138],"toxicity.":[139,150],"All":[140],"25":[141],"women":[142,260],"who":[143],"entered":[144],"evaluable":[146],"response":[148,193,200,208,257,298],"The":[151,191],"main":[152],"grade":[153],"3/4":[154],"toxicities":[155],"observed":[156],"leukopenia,":[158],"thrombocytopenia,":[159],"mucositis.":[161],"Alopecia":[162],"occurred":[163],"all":[165,187,270],"patients.":[166],"No":[167],"clinically":[168],"relevant":[169],"cardiovascular":[170],"observed.":[173],"Severe":[174],"myelosuppression":[175],"mucositis":[177],"necessitated":[178],"dose":[179,264,276],"at":[181],"courses":[182,287],"3":[185,222,245],"but":[188,263],"one":[189],"patient.":[190],"complete":[192,216,303],"rate":[194,201,209,258],"28%,":[196],"partial":[199,239],"52%":[203],"an":[205],"overall":[206],"80%.":[211],"Median":[212],"progression-free":[213,228],"survival":[214,229],"responders":[217,240],"11":[219],"months":[220,232,243],"(range,":[221,244],"24":[224],"months),":[225],"while":[226],"7+":[231],"(range":[233],"14+":[236],"months)":[237,248],"9":[247],"nonresponders.":[250],"produces":[253],"high":[255],"MBC,":[262],"necessary":[267],"almost":[269],"cases.":[271],"Toxicity":[272],"manageable":[274],"after":[275],"reduction,":[277],"allowing":[278],"be":[281],"re-treated":[282],"two":[284],"without":[288],"life-threatening":[289],"toxic":[292],"deaths.":[293],"Unfortunately,":[294],"duration":[296],"limited":[300],"even":[301],"among":[302],"responders.":[304],"Further":[305],"trials":[306],"this":[308,318],"should":[314],"explore":[315],"improvements":[316],"study":[319],"regimen.":[320]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-07-22T00:00:00"}